{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T23:41:48Z","timestamp":1788306108003,"version":"build-2803163510"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,3]]},"abstract":"<jats:p>In Poland, cervical cancer incidence and mortality still remain considerably higher than in Western European countries or North America. Recent data indicate decreasing trends in women younger than 60 years and stable trends in older women. In this article, we identified obstacles in primary and secondary prevention of cervical cancer in Poland. We analysed local legislation, management structure and organization of cervical cancer prevention in Poland and reviewed solutions available and implemented in other European countries. The main weaknesses include: (i) very low coverage of organized screening; concurrent unregistered opportunistic screening with unknown coverage and high test consumption (ii) suboptimal quality assurance in organized screening and no external quality assurance in opportunistic screening (iii) very low coverage of human papillomavirus vaccination that is not centrally reimbursed (iv) absence of pilot evaluation of (a) interventions that may improve population coverage and (b) performance of new preventive strategies. The proposed solutions are multifaceted and involve: (i) legislative and organizational regulation of cervical cancer screening aimed at comprehensive registration of procedures, data access and quality assurance (ii) pilot testing and implementation of new ways to increase coverage of cervical cancer screening, in particular among older women (iii) pilot evaluation with possible introduction of human papillomavirus-based screening and (iv) inclusion of human papillomavirus vaccination into the reimbursed national immunization program.<\/jats:p>","DOI":"10.1097\/cej.0000000000000528","type":"journal-article","created":{"date-parts":[[2019,9,13]],"date-time":"2019-09-13T02:00:34Z","timestamp":1568340034000},"page":"157-164","source":"Crossref","is-referenced-by-count":12,"title":["A roadmap for a comprehensive control of cervical cancer in Poland: integration of available solutions into current practice in primary and secondary prevention"],"prefix":"10.1097","volume":"29","author":[{"given":"Andrzej","family":"Nowakowski","sequence":"first","affiliation":[{"name":"Central Coordination Center for Cervical Cancer Screening Program, Department of Cancer Prevention, Maria Sklodowska-Curie Institute-Oncology Center, Warszawa"},{"name":"2nd Department of Gynecological Oncology, Saint John of Dukla Lublin Regional Cancer Center, Lublin"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Arbyn","sequence":"additional","affiliation":[{"name":"Sciensano, Unit of Cancer Epidemiology\/Belgian Cancer Centre, Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryla H.","family":"Turkot","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Hepatology and Oncology, Medical Center for Postgraduate Education, Warsaw"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulina","family":"Wieszczy","sequence":"additional","affiliation":[{"name":"Central Coordination Center for Cervical Cancer Screening Program, Department of Cancer Prevention, Maria Sklodowska-Curie Institute-Oncology Center, Warszawa"},{"name":"Department of Gastroenterology, Hepatology and Oncology, Medical Center for Postgraduate Education, Warsaw"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kinga","family":"Mi\u0142osz","sequence":"additional","affiliation":[{"name":"Central Coordination Center for Cervical Cancer Screening Program, Department of Cancer Prevention, Maria Sklodowska-Curie Institute-Oncology Center, Warszawa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micha\u0142 F.","family":"Kami\u0144ski","sequence":"additional","affiliation":[{"name":"Central Coordination Center for Cervical Cancer Screening Program, Department of Cancer Prevention, Maria Sklodowska-Curie Institute-Oncology Center, Warszawa"},{"name":"Department of Gastroenterology, Hepatology and Oncology, Medical Center for Postgraduate Education, Warsaw"},{"name":"Department of Gastroenterological Oncology, Maria Sklodowska-Curie Institute-Oncology Center, Warsaw"},{"name":"Department of Health Management and Health Economics, University of Oslo, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Didkowska","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Cancer Prevention"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariusz","family":"Bidzi\u0144ski","sequence":"additional","affiliation":[{"name":"Gynecologic Oncology Department"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W\u0142odzimierz","family":"Olszewski","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Diagnostics, Maria Sklodowska-Curie Institute\u2013Oncology Center, Warsaw"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miros\u0142aw","family":"Wielgo\u015b","sequence":"additional","affiliation":[{"name":"1st Department of Obstetrics and Gynecology, Medical University of Warsaw, Warsaw"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej","family":"Krzakowski","sequence":"additional","affiliation":[{"name":"Lung and Thoracic Tumors Department, Maria Sklodowska-Curie Institute-Oncology Center, Warsaw"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernest","family":"Kuchar","sequence":"additional","affiliation":[{"name":"Department of Pediatrics with Clinical Assessment Unit, Medical University of Warsaw"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Walewski","sequence":"additional","affiliation":[{"name":"Department of Lymphoid Malignancies, Maria Sklodowska-Curie Institute\u2013Oncology Center, Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230902","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1097\/IGC.0000000000000374","article-title":"Cervical carcinoma in the European union: an update on disease burden, screening program state of activation, and coverage as of March 2014.","volume":"25","author":"Altobelli","year":"2015","journal-title":"Int J Gynecol Cancer"},{"key":"R4-20230902","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1093\/annonc\/mdp471","article-title":"European Guidelines for Quality Assurance in Cervical Cancer Screening. Second edition\u2013summary document.","volume":"21","author":"Arbyn","year":"2010","journal-title":"Ann Oncol"},{"key":"R5-20230902","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/01.AOG.0000296488.85807.b3","article-title":"Liquid compared with conventional cervical cytology: a systematic review and meta-analysis.","volume":"111","author":"Arbyn","year":"2008","journal-title":"Obstet Gynecol"},{"issue":"Suppl 5","key":"R6-20230902","doi-asserted-by":"crossref","first-page":"F88","DOI":"10.1016\/j.vaccine.2012.06.095","article-title":"Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer.","volume":"30","author":"Arbyn","year":"2012","journal-title":"Vaccine"},{"key":"R7-20230902","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.cmi.2015.04.015","article-title":"Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening?.","volume":"21","author":"Arbyn","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"R8-20230902","first-page":"CD009069","article-title":"Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.","volume":"5","author":"Arbyn","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"R9-20230902","doi-asserted-by":"crossref","first-page":"118","DOI":"10.7326\/M15-2735","article-title":"Genotyping for human papillomavirus types 16 and 18 in women with minor cervical lesions: a systematic review and meta-analysis.","volume":"166","author":"Arbyn","year":"2017","journal-title":"Ann Intern Med"},{"issue":"Suppl 7","key":"R10-20230902","doi-asserted-by":"crossref","first-page":"H71","DOI":"10.1016\/j.vaccine.2013.04.086","article-title":"Cost-effectiveness of cervical cancer prevention in central and eastern europe and central asia.","volume":"31","author":"Berkhof","year":"2013","journal-title":"Vaccine"},{"key":"R11-20230902","doi-asserted-by":"crossref","first-page":"e453","DOI":"10.1016\/S2214-109X(16)30099-7","article-title":"Global estimates of human papillomavirus vaccination coverage by region and income level: a pooled analysis.","volume":"4","author":"Bruni","year":"2016","journal-title":"Lancet Glob Health"},{"key":"R12-20230902","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.bpobgyn.2017.08.010","article-title":"Population-based HPV vaccination programmes are safe and effective: 2017 update and the impetus for achieving better global coverage.","volume":"47","author":"Brotherton","year":"2018","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"R13-20230902","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1080\/01621459.1957.10501404","article-title":"Confidence intervals for the product of two binomial parameters.","volume":"52","author":"Buehler","year":"1957","journal-title":"J Am Stat Assoc"},{"key":"R16-20230902","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1002\/ijc.31261","article-title":"Eurogin roadmap 2017: triage strategies for the management of HPV-positive women in cervical screening programs.","volume":"143","author":"Cuschieri","year":"2018","journal-title":"Int J Cancer"},{"key":"R17-20230902","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S1470-2045(10)70230-8","article-title":"Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study.","volume":"11","author":"de Sanjose","year":"2010","journal-title":"Lancet Oncol"},{"key":"R19-20230902","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju153","article-title":"Reassurance against future risk of precancer and cancer conferred by a negative human papillomavirus test.","volume":"106","author":"Gage","year":"2014","journal-title":"J Natl Cancer Inst"},{"key":"R21-20230902","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1002\/ijc.31212","article-title":"Initial results of population based cervical cancer screening program using HPV testing in one million turkish women.","volume":"142","author":"Gultekin","year":"2018","journal-title":"Int J Cancer"},{"key":"R22-20230902","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13027-017-0129-6","article-title":"Estimation of the overall burden of cancers, precancerous lesions, and genital warts attributable to 9-valent HPV vaccine types in women and men in Europe.","volume":"12","author":"Hartwig","year":"2017","journal-title":"Infect Agent Cancer"},{"key":"R24-20230902","first-page":"CD008587","article-title":"Cytology versus HPV testing for cervical cancer screening in the general population.","volume":"8","author":"Koliopoulos","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"R25-20230902","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/eurpub\/cky200","article-title":"The legal framework for European cervical cancer screening programmes.","volume":"29","author":"M\u00e1jek","year":"2019","journal-title":"Eur J Public Health"},{"key":"R26-20230902","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/ijc.24010","article-title":"Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older.","volume":"124","author":"Meijer","year":"2009","journal-title":"Int J Cancer"},{"key":"R27-20230902","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1186\/s12885-015-1242-9","article-title":"The implementation of an organised cervical screening programme in Poland: an analysis of the adherence to European guidelines.","volume":"15","author":"Nowakowski","year":"2015","journal-title":"BMC Cancer"},{"key":"R29-20230902","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s10654-017-0291-6","article-title":"Trends in cervical cancer incidence and mortality in Poland: is there an impact of the introduction of the organised screening?.","volume":"32","author":"Nowakowski","year":"2017","journal-title":"Eur J Epidemiol"},{"key":"R30-20230902","first-page":"116","article-title":"Financial incentives and cervical cancer screening participation in Ontario\u2019s primary care practice models.","volume":"12","author":"Pendrith","year":"2016","journal-title":"Healthc Policy"},{"key":"R32-20230902","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0140-6736(13)62218-7","article-title":"Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials.","volume":"383","author":"Ronco","year":"2014","journal-title":"Lancet"},{"key":"R33-20230902","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1001\/jama.2009.1569","article-title":"Comparison of liquid-based cytology with conventional cytology for detection of cervical cancer precursors: a randomized controlled trial.","volume":"302","author":"Siebers","year":"2009","journal-title":"JAMA"},{"key":"R34-20230902","first-page":"1331","article-title":"Conventional cytology versus liquid based cytology in cervical pathology: correspondences and inconsistencies in diagnosis, advantages and limits.","volume":"55","author":"Simion","year":"2014","journal-title":"Rom J Morphol Embryol"},{"key":"R36-20230902","doi-asserted-by":"crossref","first-page":"65","DOI":"10.5603\/NJO.2018.0011","article-title":"External audit of providers of the Cervical Cancer Prevention Programme in Poland in 2016\/2017.","volume":"68","author":"Turkot","year":"2018","journal-title":"Nowotwory J Oncol"},{"key":"R37-20230902","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/j.healthpol.2018.08.005","article-title":"Results of a health systems approach to identify barriers to population-based cervical and colorectal cancer screening programmes in six European countries.","volume":"122","author":"Turnbull","year":"2018a","journal-title":"Health Policy"},{"key":"R38-20230902","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.healthpol.2018.08.003","article-title":"A health systems approach to identifying barriers to breast cancer screening programmes. Methodology and application in six European countries.","volume":"122","author":"Turnbull","year":"2018b","journal-title":"Health Policy"},{"key":"R40-20230902","first-page":"241","article-title":"Human papillomavirus vaccines: WHO position paper, May 2017.","volume":"92","year":"2017","journal-title":"Wkly Epidemiol Rec"},{"issue":"Suppl","key":"R41-20230902","first-page":"81","article-title":"Screening for cervical cancer in poland.","volume":"14","author":"Wronkowski","year":"1993","journal-title":"Eur J Gynaecol Oncol"}],"container-title":["European Journal of Cancer Prevention"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CEJ.0000000000000528","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T01:05:29Z","timestamp":1693616729000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CEJ.0000000000000528"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/cej.0000000000000528","relation":{},"ISSN":["0959-8278"],"issn-type":[{"value":"0959-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]}}}